Summary
First Solar, Inc. reported a decrease in net sales for the three months ended September 30, 2021, to $583.5 million from $927.6 million in the prior year period, primarily due to the sale of certain projects in the prior year. While module sales volume increased, a decrease in average selling price per watt and higher logistics costs impacted gross profit, which declined to 21.4% from 31.6% year-over-year. The company continues to invest in expanding its manufacturing capacity, announcing plans for new facilities in Ohio and India, signaling a strategic focus on growth and long-term market positioning. Financially, First Solar maintained a strong liquidity position with $1.9 billion in cash, cash equivalents, and marketable securities as of September 30, 2021. The company also reported positive net cash from operating activities for the nine months ended September 30, 2021, a significant improvement from the prior year's negative cash flow. Despite ongoing challenges in the solar industry, including supply chain disruptions and competitive pricing, First Solar remains focused on its core module business and strategic expansion plans.
Financial Highlights
54 data points| Revenue | $583.50M |
| Cost of Revenue | $458.92M |
| Gross Profit | $124.58M |
| R&D Expenses | $25.43M |
| SG&A Expenses | $43.48M |
| Operating Expenses | $71.85M |
| Operating Income | $50.87M |
| Interest Expense | $2.96M |
| Net Income | $45.20M |
| EPS (Basic) | $0.43 |
| EPS (Diluted) | $0.42 |
| Shares Outstanding (Basic) | 106.32M |
| Shares Outstanding (Diluted) | 106.90M |
Key Highlights
- 1Net sales decreased 37% to $583.5 million for Q3 2021 compared to $927.6 million for Q3 2020, primarily due to prior period project sales.
- 2Gross profit margin declined to 21.4% in Q3 2021 from 31.6% in Q3 2020, impacted by lower average selling prices, increased logistics costs, and a higher module collection and recycling liability.
- 3The company announced plans to expand manufacturing capacity with new facilities in Ohio, USA, and India, expected to be operational in 2023.
- 4Cash, cash equivalents, and marketable securities stood at $1.9 billion as of September 30, 2021, indicating a strong liquidity position.
- 5Net cash provided by operating activities for the nine months ended September 30, 2021 was $203.1 million, a significant improvement from a use of $149.2 million in the same period of 2020.
- 6Research and development expenses increased by 11% for the three months ended September 30, 2021, reflecting continued investment in technology improvements.
- 7The company is experiencing delays in its CuRe program due to manufacturing challenges, potentially impacting future revenue and requiring contract amendments.